Pediatric Epilepsy Therapeutics Market By Disease Type, Therapeutics and End User – Global Industry Analysis & Forecast to 2025
Pediatric Epilepsy Therapeutics Market By Disease Type (Childhood absence epilepsy (CAE), Infantile spasms (or West syndrome), Benign rolandic epilepsy (BRE), Juvenile myoclonic epilepsy (JME), Lennox-gastaut syndrome (LGS) and Others) Therapeutics (Dietary supplements, Surgical therapies, Anti-epileptic drugs and Vagal nerve stimulation) End User (Neurology Centers, Ambulatory Surgical Centers, Hospitals, Home care settings) – Global Industry Analysis & Forecast to 2025
Industry Outlook and Trend Analysis
The Pediatric Epilepsy Therapeutics Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Epilepsy is an incessant neurological disorder that prompts repetitive seizures, described by brief and imperceptible scenes of automatic development including either a body part or the whole body. The main reason for epilepsy is obscure notwithstanding, a few people develop epilepsy as the aftereffect of strokes, trauma, infections, brain tumor and birth complications. As indicated by World Health Organization (WHO), around 50 million of total populace is as of now dealing with epilepsy making it a standout amongst the most well-known neurological disorder around the world. The ailment is observed to be pervasive in pediatric populace in comparison to the adult populace prompting more prominent likelihood for general specialists to counsel patients with epilepsy on a daily basis.
Drivers and Restraints
Constant rise in different neurological issues among youngsters' is the essential factor contributing towards development of pediatric epilepsy therapeutics market over the figure time frame. Additionally developing endeavors to build up AED's with novel component of activity is foreseen to enhance the pattern of treatment. Rising prevalence of various neurological problems have brought about interest in extensive research and development to introduce novel treatments for pediatric epilepsy treatment.
North America is the dominant region of the market and is anticipated to continue leading the market over the forecast period. Asia Pacific is anticipated to develop substantially.
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
Johnson & Johnson
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?